00897nas a2200361   4500000000100000008004100001260001300042653001500055653001000070653000900080653001300089653001500102653001200117653002200129653001100151653001100162653001400173653001200187653000900199653001600208653002300224653002400247653001200271100001600283700001600299700001500315245008200330856005900412300001100471490000700482050003200489022001400521       1983                            d  c1983 Dec10aAdolescent10aAdult10aAged10aCapsules10aCreatinine10aDapsone10aDrug Combinations10aFemale10aHumans10aIsoniazid10aleprosy10aMale10aMiddle Aged10aPatient Compliance10aSelf Administration10aTablets1 aStanley J N1 aPearson J M1 aEllard G A00aAn investigation of dapsone compliance using an isoniazid-marked formulation.  uhttp://leprev.ilsl.br/pdfs/1983/v54n4/pdf/v54n4a07.pdf  a317-250 v54  aInfolep Library - available  a0305-7518